Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Cyril Allouche currently holds 6,400 shares of Revance Therapeutics, Inc. (RVNC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cyril Allouche has been a net seller of RVNC stock. They have purchased $0 and sold $99.3K worth of shares.
Cyril Allouche's most recent insider trade was on Mar 18, 2019, when they sold 498 shares at $15.48 per share.
Cyril Allouche serves as Executive at Revance Therapeutics, Inc. (RVNC). They have executed 14 insider transactions totaling $99.3K over their tenure at the company.
Cyril Allouche holds the position of Executive at Revance Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Cyril Allouche has shown a selling trading pattern, with $0 in total purchases and $99.3K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Cyril Allouche was on Nov 9, 2018, when they sold $51.9K worth of RVNC shares. This transaction involved 2,188 shares at $23.72 per share.
Cyril Allouche currently owns 6,400 shares of Revance Therapeutics, Inc. (RVNC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Cyril Allouche's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Cyril Allouche has 14 Form 4 filings on record as an insider at Revance Therapeutics, Inc..
Set alerts for Cyril Allouche and 40,000+ other insiders.